Skip to content Skip to footer
Exact Sciences

Exact Sciences launches Oncodetect for Molecular Residual Disease (MRD) Detection

Shots:Exact Sciences has launched Oncodetect to detect MRD across multiple solid tumors, with its efficacy supported by strong clinical validation, incl. ~5yrs. of follow-up data from the Alpha-CORRECT studyAddiitonally, clinical & analytical validation studies across multiple solid tumors are underway, supported by strategic partnerships for multi-cancer evidence generationOncodetect test provides clear “Detected”…

Read more